Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for RegeneRx Biopharmaceuticals, Inc., dated Friday Nov. 15.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.


Published Date:   Friday Nov. 15

Company Name:     RegeneRx Biopharmaceuticals, Inc.

Address:          3 Bethesda Metro Center, Suite 700
                  Bethesda, MD  20814-5330

Main Telephone
 Number:          301-961-1992

Internet Home
 Page Address
  (URL)           RegeneRx.com

Chief Executive
 Officer:         J.J. Finkelstein

Chief Financial
 Officer:         J.J. Finkelstein

Investor Relations
 E-mail address:  Info@RegeneRx.com

Public Relations
 E-mail address:  Info@RegeneRx.com

Industry:         Biotechnology

Trading Symbol/
 Exchange:        OTC BB: RGRX

Market Makers:    NITE,SCHB,WIEN,GSCO

    Company description:

Annual sales figures: 0
Stock highs and lows: .72 and .25
Net income/loss 2001: (150,609)

COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 15, 2002
Words:133
Previous Article:Corporate Profile for OAO Technology Solutions, dated Nov. 15, 2002.
Next Article:Cocooning Trend is Over, Marketing Consultant Pam Danziger Says; Dominant Lifestyle Trend Called Cocooning Recedes as Consumers Reconnect With the...



Related Articles
RegeneRx Biopharmaceuticals to Present at BIO 2003.
RegeneRx Listed on American Stock Exchange.
RegeneRx Rings the AMEX Opening Bell.
RegeneRx Names Chief Financial Officer.
RegeneRx Names Executive Director, Regulatory Affairs.
Dr. Gabriel Sosne Joins RegeneRx Medical and Scientific Advisory Board.
RegeneRx to Present at the 3rd Annual ThinkEquity Growth Conference.
RegeneRx to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference.
RegeneRx Biopharmaceuticals Launches New Web Site.
RegeneRx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year End Earnings Release and Conference Call.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles